Mylona, Athina, Andrieu-Soler, Charlotte, Thongjuea, Supat, Martella, Andrea, Soler, Eric, Jorna, Ruud, Hou, Jun, Kockx, Christel, van Ijcken, Wilfred, Lenhard, Boris, and others. (2013) Genome-wide analysis shows that Ldb1 controls essential hematopoietic genes/pathways in mouse early development and reveals novel players in hematopoiesis. Blood, 121 (15). pp. 2902-13. ISSN 1528-0020. (KAR id:114688)
|
PDF
Author's Accepted Manuscript
Language: English
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
|
|
|
Download this file (PDF/1MB) |
Preview |
| Request a format suitable for use with assistive technology e.g. a screenreader | |
Abstract
The first site exhibiting hematopoietic activity in mammalian development is the yolk-sac blood island, which originates from the hemangioblast. Here we performed differentiation assays, as well as genome-wide molecular and functional studies in blast colony-forming cells to gain insight into the function of the essential Ldb1 factor in early primitive hematopoietic development. We show that the previously reported lack of yolk-sac hematopoiesis and vascular development in Ldb1(-/-) mouse result from a decreased number of hemangioblasts and a block in their ability to differentiate into erythroid and endothelial progenitor cells. Transcriptome analysis and correlation with the genome-wide binding pattern of Ldb1 in hemangioblasts revealed a number of direct-target genes and pathways misregulated in the absence of Ldb1. The regulation of essential developmental factors by Ldb1 defines it as an upstream transcriptional regulator of hematopoietic/endothelial development. We show the complex interplay that exists between transcription factors and signaling pathways during the very early stages of hematopoietic/endothelial development and the specific signaling occurring in hemangioblasts in contrast to more advanced hematopoietic developmental stages. Finally, by revealing novel genes and pathways not previously associated with early development, our study provides novel candidate targets to manipulate the differentiation of hematopoietic and/or endothelial cells.
| Item Type: | Article |
|---|---|
| Institutional Unit: | Schools > Kent and Medway Medical School |
| Former Institutional Unit: |
There are no former institutional units.
|
| Funders: |
Dutch Research Council (https://ror.org/04jsz6e67)
Royal Netherlands Academy of Arts and Sciences (https://ror.org/043c0p156) |
| Depositing User: | Athina Mylona |
| Date Deposited: | 11 May 2026 08:58 UTC |
| Last Modified: | 11 May 2026 08:59 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/114688 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):

Total Views
Total Views